Basal Plus GLP1-ra on Glycemic Variability in CKD

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 28, 2022

Primary Completion Date

October 30, 2024

Study Completion Date

October 30, 2024

Conditions

Diabetes MellitusDiabetic Kidney Disease

Interventions

DRUG

Dulaglutide

Dulaglutide once weekly subcutaneous

DRUG

Insulin Degludec

Insulin degludec once daily

DEVICE

Continuous glucose monitor

Dexcom G6 CGM system

Trial Locations (1)

Prince of Wales Hospital, Shatin

All Listed Sponsors

lead

Elaine Chow

OTHER